tradingkey.logo

EMA Says Norgine B.V. Withdrew Application For Marketing Authorisation Of Ifinwil On 18 July

ReutersJul 25, 2025 1:24 PM

- EMA:

  • EMA: ON 18 JULY, NORGINE B.V. WITHDREW APPLICATION FOR MARKETING AUTHORISATION OF IFINWIL FOR TREATMENT OF HIGH-RISK NEUROBLASTOMA

  • EMA: IN APPLICATION WITHDRAWAL LETTER, NORGINE SAID IT NEEDED ADDITIONAL TIME TO COMPREHENSIVELY ADDRESS ALL QUESTIONS RAISED BY EMA ABOUT IFINWIL

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI